Phibro Animal Health (PAHC) Other Working Capital Changes (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Other Working Capital Changes came in at $603000.0 in Q1 2026, down 69.47% year-on-year from $2.0 million in Q1 2025, and up 107.97% quarter-over-quarter from -$7.6 million in Q4 2025.
Phibro Animal Health (PAHC) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Phibro Animal Health's Other Working Capital Changes history runs 14 years deep, the most recent figure standing at $603000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 69.47% year-over-year to $603000.0 in Q1 2026; TTM through Mar 2026 was $2.0 million, a 1714.68% increase from a year earlier, with the FY2025 full-year figure at $16.3 million, up 248.06% from the prior year.
- Other Working Capital Changes rose to $603000.0 in Q1 2026 per PAHC's latest filing, from -$7.6 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $8.6 million in Q2 2025 and bottomed at -$7.6 million in Q2 2024.
- The 5-year median for Other Working Capital Changes is $306000.0 (2025), against an average of $430117.6.
- Across the five-year window, Other Working Capital Changes surged 54971.43% in 2022 and tumbled 12162.9% in 2024, its largest moves.
- Year by year, Other Working Capital Changes stood at $62000.0 in 2022, then slumped by 8537.1% to -$5.2 million in 2023, then surged by 190.96% to $4.8 million in 2024, then sank by 259.0% to -$7.6 million in 2025, then jumped by 107.97% to $603000.0 in 2026.
- Per Business Quant, the three latest PAHC Other Working Capital Changes figures stand at $603000.0 (Q1 2026), -$7.6 million (Q4 2025), and $306000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 603,000.00 |
| Mar 31, 2026 | 603,000.00 |
| Mar 31, 2026 | 603,000.00 |
| Dec 31, 2025 | -7.57 Mn |
| Dec 31, 2025 | -7.57 Mn |
| Dec 31, 2025 | -7.57 Mn |
| Sep 30, 2025 | 306,000.00 |
| Sep 30, 2025 | 306,000.00 |
| Sep 30, 2025 | 306,000.00 |
| Jun 30, 2025 | 8.63 Mn |
| Jun 30, 2025 | 8.63 Mn |
| Jun 30, 2025 | 8.63 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Sep 30, 2024 | 979,000.00 |
| Sep 30, 2024 | 979,000.00 |